Vycor Medical (VYCO) Net Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,599.00 |
| Dec 31, 2025 | 5,367.00 |
| Sep 30, 2025 | 10,004.00 |
| Jun 30, 2025 | 10,670.00 |
| Mar 31, 2025 | 5,608.00 |
| Dec 31, 2024 | 6,518.00 |
| Sep 30, 2024 | 5,835.00 |
| Jun 30, 2024 | 4,252.00 |
| Mar 31, 2024 | 4,045.00 |
| Dec 31, 2023 | 8,285.00 |
| Sep 30, 2023 | -47.00 |
| Jun 30, 2023 | 15,293.00 |
| Mar 31, 2023 | 10,733.00 |
| Dec 31, 2022 | 9,607.00 |
| Sep 30, 2022 | 6,644.00 |
| Jun 30, 2022 | 8,704.00 |
| Mar 31, 2022 | 3,544.00 |
| Dec 31, 2021 | 7,196.00 |
| Sep 30, 2021 | 8,221.00 |
| Jun 30, 2021 | 7,858.00 |
| Mar 31, 2021 | 1,696.00 |
| Sep 30, 2020 | 11,317.00 |
| Jun 30, 2020 | 4,505.00 |
| Mar 31, 2020 | 14,342.00 |
| Sep 30, 2019 | 28,718.00 |
| Jun 30, 2019 | 38,322.00 |
| Mar 31, 2019 | 12,237.00 |
| Dec 31, 2018 | 9,405.00 |
| Sep 30, 2018 | 9,224.00 |
| Jun 30, 2018 | 13,467.00 |
| Mar 31, 2018 | 13,568.00 |
| Dec 31, 2017 | 4,980.00 |
| Sep 30, 2017 | 20,089.00 |
| Jun 30, 2017 | 18,336.00 |
| Mar 31, 2017 | 7,023.00 |
| Dec 31, 2016 | 4,937.00 |
| Sep 30, 2016 | 36,691.00 |
| Jun 30, 2016 | 120,895.00 |
| Mar 31, 2016 | 49,083.00 |
| Sep 30, 2015 | 25,755.00 |
| Jun 30, 2015 | 41,468.00 |